A federal judge in Boston ruled on Thursday, November 19, that the Trump administration cannot impose funding conditions barring health-care providers from acknowledging the gender identity of their transgender patients or from providing them gender-affirming care, striking down a central piece of the administration's limits on HIV-treatment funding.
U.S. District Judge William Young sided with a group of national HIV medical associations and health-care providers that challenged grant conditions imposed on money from the Ryan White HIV/AIDS Program, the federal programme created by Congress in 1990 to provide medical care for low-income and uninsured people living with HIV.
What the funding conditions said
Beginning in March, the Health Resources and Services Administration (HRSA), the division of the U.S. Department of Health and Human Services that runs the Ryan White programme, added conditions to its grants to carry out President Donald Trump's executive order directing the federal government to recognise only two sexes, male and female.
The conditions required providers to ensure funding supported activities using what the government called "sex-based definitions grounded in biological reality" and not "social or medical experimentation". In practice, the lawsuit said, they barred providers from acknowledging their transgender patients' identities or using patients' preferred pronouns, and from using programme funds for gender-affirming medical care.
Why the judge struck them down
Judge Young, who was appointed by Republican President Ronald Reagan, said in his 165-page ruling that the conditions were designed to suppress what the administration considered to be "dangerous ideas", in violation of the U.S. Constitution's First Amendment, by penalising doctors for acknowledging that transgender people exist and for referring to patients by their preferred pronouns.
He also ruled that the restrictions reflected unconstitutional discrimination on the basis of sex, in violation of the Constitution's Fifth Amendment.
The court declared the conditions unlawful, vacated them and permanently blocked the government from imposing the conditions, or any similar policy, on the associational plaintiffs' members — a group Lambda Legal says covers virtually every HIV care provider in the United States.
The case behind the ruling
The lawsuit, American Academy of HIV Medicine et al. v. Health Resources and Services Administration et al., was filed in June by the American Academy of HIV Medicine, the HIV Medicine Association, the International Association of Providers of AIDS Care and individual provider plaintiffs. Lambda Legal and Herbert Smith Freehills Kramer (US) LLP represented the plaintiffs.
Judge Young decided the case after a bench trial on September 23. He had urged the administration at the end of the trial to settle, but the administration rejected a settlement proposal from the plaintiffs, according to an October 2 court filing.
The plaintiffs argued that the funding conditions conflicted with the Ryan White programme's statutory mandate to provide comprehensive medical services to HIV patients, care that has historically included hormone therapy for transgender people.
What happens next
The administration's next step, if it chooses to fight on, would be an appeal to the First Circuit Court of Appeals. The ruling does not end the wider legal battle over the executive order itself, but it removes, for now, the funding threat that providers said forced them to choose between federal money and treating their patients according to medical need.
For patients, the practical effect is that Ryan White providers can again treat transgender patients on the basis of medical need and best practice, without the funding conditions that Lambda Legal said had put care at risk. Clinics in every state, including states with large South Asian and immigrant communities, work under the same federal programme.
Reporting: Reuters; Lambda Legal; American Academy of HIV Medicine.
Source: Reuters
